Literature DB >> 15496426

Polymorphisms in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma: a candidate gene approach.

Nobuyoshi Jinnai1, Takuro Sakagami, Takashi Sekigawa, Miho Kakihara, Toshiaki Nakajima, Kenichi Yoshida, Shin Goto, Takashi Hasegawa, Takeshi Koshino, Yoshinori Hasegawa, Hiromasa Inoue, Naohito Suzuki, Yasuyuki Sano, Ituro Inoue.   

Abstract

Aspirin-intolerant asthma (AIA) is a subtype of bronchial asthma characterized by development of bronchoconstriction evoked by non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDs inhibit the cyclooxygenase pathway, leading to enhancement of the lipoxygenase pathway. We evaluated allelic association of 370 single nucleotide polymorphisms (SNPs) of 63 candidate genes, mostly from the arachidonic acid metabolic cascade, with AIA. After two rounds of screening with 198 AIA patients, multiple SNPs in the prostaglandin E(2) receptor subtype 2 (EP2) gene were associated with AIA (P<0.05). Among the 77 SNPs identified in the EP2 gene, we selected 17 SNPs on the basis of linkage disequilibrium and allelic frequencies (minor allele frequency >0.1) for further association study. SNPs in the promoter region of the EP2 gene, uS5, uS5b, and uS7, were significantly associated with AIA (permutation P=0.039-0.001). Analysis of haplotypes constructed according to the LD pattern showed a significant association with AIA (permutation P=0.001). The most significantly associated SNP, uS5, located in the regulatory region of the EP2 gene, was in a STATs-binding consensus sequence [AIA 31.1% versus control 22.1% (permutation P=0.0016) or versus aspirin-tolerant asthma 22.2% (permutation P=0.0017)]. Although STAT1 binding was not observed in gel mobility shift assay with HeLa nuclear extract, an unidentified protein was specifically bound to the allelic sequence. In in vitro reporter assay in HCT116 cells, the site containing the uS5 allele showed reduced transcription activity. Taken together, these results suggest that uS5 allele serves as a target of a transcription repressor protein. A functional SNP of the EP2 gene associated with risk of AIA should decrease the transcription level, resulting in reduction of the PGE(2) braking mechanism of inflammation and involvement in the molecular mechanism underlying AIA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15496426     DOI: 10.1093/hmg/ddh332

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  32 in total

1.  ADAM33 polymorphisms are associated with aspirin-intolerant asthma in the Japanese population.

Authors:  Takuro Sakagami; Nobuyoshi Jinnai; Toshiaki Nakajima; Takashi Sekigawa; Takashi Hasegawa; Eiichi Suzuki; Ituro Inoue; Fumitake Gejyo
Journal:  J Hum Genet       Date:  2006-10-24       Impact factor: 3.172

Review 2.  Gene-environment interactions in asthma.

Authors:  F Castro-Giner; F Kauffmann; R de Cid; M Kogevinas
Journal:  Occup Environ Med       Date:  2006-11       Impact factor: 4.402

Review 3.  Discovery and verification of functional single nucleotide polymorphisms in regulatory genomic regions: current and developing technologies.

Authors:  Brian N Chorley; Xuting Wang; Michelle R Campbell; Gary S Pittman; Maher A Noureddine; Douglas A Bell
Journal:  Mutat Res       Date:  2008-05-04       Impact factor: 2.433

4.  Development of a genetic marker set to diagnose aspirin-exacerbated respiratory disease in a genome-wide association study.

Authors:  H S Chang; S W Shin; T H Lee; D J Bae; J S Park; Y H Kim; S T Uh; B W Choi; M K Kim; I S Choi; B L Park; H D Shin; C S Park
Journal:  Pharmacogenomics J       Date:  2015-02-24       Impact factor: 3.550

5.  Aspirin and decreased adult-onset asthma: randomized comparisons from the physicians' health study.

Authors:  R Graham Barr; Tobias Kurth; Meir J Stampfer; Julie E Buring; Charles H Hennekens; J Michael Gaziano
Journal:  Am J Respir Crit Care Med       Date:  2006-10-26       Impact factor: 21.405

6.  Prostaglandin E₂ suppresses allergic sensitization and lung inflammation by targeting the E prostanoid 2 receptor on T cells.

Authors:  Zbigniew Zasłona; Katsuhide Okunishi; Emilie Bourdonnay; Racquel Domingo-Gonzalez; Bethany B Moore; Nicholas W Lukacs; David M Aronoff; Marc Peters-Golden
Journal:  J Allergy Clin Immunol       Date:  2013-09-24       Impact factor: 10.793

7.  Association study on chromosome 20q11.21-13.13 locus and its contribution to type 2 diabetes susceptibility in Japanese.

Authors:  Toshihito Tanahashi; Dai Osabe; Kyoko Nomura; Shuichi Shinohara; Hitoshi Kato; Eiichiro Ichiishi; Naoto Nakamura; Toshikazu Yoshikawa; Yoichiro Takata; Tatsuro Miyamoto; Hiroshi Shiota; Parvaneh Keshavarz; Yuka Yamaguchi; Kiyoshi Kunika; Maki Moritani; Hiroshi Inoue; Mitsuo Itakura
Journal:  Hum Genet       Date:  2006-09-06       Impact factor: 4.132

8.  Genome-wide and follow-up studies identify CEP68 gene variants associated with risk of aspirin-intolerant asthma.

Authors:  Jeong-Hyun Kim; Byung-Lae Park; Hyun Sub Cheong; Joon Seol Bae; Jong Sook Park; An Soo Jang; Soo-Taek Uh; Jae-Sung Choi; Yong-Hoon Kim; Mi-Kyeong Kim; Inseon S Choi; Sang Heon Cho; Byoung Whui Choi; Choon-Sik Park; Hyoung Doo Shin
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

Review 9.  Prostaglandins in asthma and allergic diseases.

Authors:  R Stokes Peebles
Journal:  Pharmacol Ther       Date:  2018-08-03       Impact factor: 12.310

Review 10.  Pathogenesis of aspirin-exacerbated respiratory disease and reactions.

Authors:  Tanya M Laidlaw; Joshua A Boyce
Journal:  Immunol Allergy Clin North Am       Date:  2012-12-23       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.